Matthew M. Medlock

440 total citations
7 papers, 357 citations indexed

About

Matthew M. Medlock is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew M. Medlock has authored 7 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew M. Medlock's work include Antifungal resistance and susceptibility (2 papers), HIV/AIDS drug development and treatment (2 papers) and Viral Infections and Immunology Research (1 paper). Matthew M. Medlock is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), HIV/AIDS drug development and treatment (2 papers) and Viral Infections and Immunology Research (1 paper). Matthew M. Medlock collaborates with scholars based in United States and Japan. Matthew M. Medlock's co-authors include Lei Ma, Gopal Krishna, James F. McLeod, Allen Moton, Craig A. Sponseller, Stuart Campbell, Roger Morgan, Christine Yu, David S. Small and Xin Yu and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Matthew M. Medlock

7 papers receiving 350 citations

Peers

Matthew M. Medlock
Allen Moton United States
R.E. Aarnoutse Netherlands
Patricia K. Mydlow United States
Henry Pertinez United Kingdom
Alan E. Hassell United States
Catherine A. Knupp United States
Donald M. Hilligoss United States
Roeland E. Wasmann South Africa
Allen Moton United States
Matthew M. Medlock
Citations per year, relative to Matthew M. Medlock Matthew M. Medlock (= 1×) peers Allen Moton

Countries citing papers authored by Matthew M. Medlock

Since Specialization
Citations

This map shows the geographic impact of Matthew M. Medlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Medlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Medlock more than expected).

Fields of papers citing papers by Matthew M. Medlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Medlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Medlock. The network helps show where Matthew M. Medlock may publish in the future.

Co-authorship network of co-authors of Matthew M. Medlock

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Medlock. A scholar is included among the top collaborators of Matthew M. Medlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Medlock. Matthew M. Medlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Yu, Christine, Stuart Campbell, Craig A. Sponseller, et al.. (2014). Steady-State Pharmacokinetics of Darunavir/Ritonavir and Pitavastatin when Co-administered to Healthy Adult Volunteers. Clinical Drug Investigation. 34(7). 475–482. 12 indexed citations
2.
Morgan, Roger, et al.. (2012). Effects of Steady-State Lopinavir/Ritonavir on the Pharmacokinetics of Pitavastatin in Healthy Adult Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(2). 158–164. 24 indexed citations
3.
Davenport, James M., Paul S. Covington, Mark H. Gotfried, et al.. (2012). Summary of Pharmacokinetics and Tissue Distribution of a Broad‐Spectrum Fluoroquinolone, JNJ‐Q2. Clinical Pharmacology in Drug Development. 1(4). 121–130. 11 indexed citations
4.
Krishna, Gopal, et al.. (2010). Lack of Pharmacokinetic Drug Interaction Between Oral Posaconazole and Caspofungin or Micafungin. The Journal of Clinical Pharmacology. 51(1). 84–92. 17 indexed citations
5.
O’Mara, Edward, Claudia Kasserra, John Huddlestone, et al.. (2010). Effect of Vicriviroc on the QT/Corrected QT Interval and Central Nervous System in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 54(6). 2448–2454. 9 indexed citations
6.
Krishna, Gopal, Allen Moton, Lei Ma, Matthew M. Medlock, & James F. McLeod. (2008). Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 53(3). 958–966. 283 indexed citations
7.
Medlock, Matthew M., Louis R. Cantilena, Mark C. Haigney, et al.. (2003). Cardiovascular Effects of Intravenous Cocaine in Human Volunteers. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026